mROS‑calcium feedback loop promotes lethal ventricular arrhythmias and sudden cardiac death in early myocardial ischemia

• Published in: International journal of molecular medicine 2024-01, Vol.53 (1), p.1, Article 5
• Main Authors: Zhou, Danya, Zhang, Ye, Zhu, Mengting, Zhang, Xiaojun, Zhang, Xiao Juan, Lv, Junyao, Tang, Wanting, Weng, Qi, Lin, Yang, Tong, Lejun, Zhong, Zhiwei, Zhang, Yanmei, Zhang, Mengxuan, Lai, Minchao, Wang, Dian
• Format: Article
• Language: English
• Subjects: Arrhythmia; Cardiac arrest; Cardiac arrhythmia; Cardiovascular disease; Coronary vessels; Electrocardiography; Heart; Hypoxia; Ischemia; Kinases; Laboratory animals; Mitochondria; Myocardial ischemia; Ostomy; Oxidation; Phosphorylation; Proteins; Reactive oxygen species; Scientific equipment and supplies industry; Software
• ISSN: 1107-3756; 1791-244X
• DOI: 10.3892/ijmm.2023.5329

Lethal ventricular arrhythmia-sudden cardiac death (LVA-SCD) occurs frequently during the early stage of myocardial ischemia (MI). However, the mechanism underlying higher LVA-SCD incidence is still poorly understood. The present study aimed to explore the role of mitochondrial reactive oxygen species (mROS) and C[a.sup.2+] crosstalk in promoting LVA-SCD in early MI. RyR2 S2814A mice and their wild-type littermates were used. MitoTEMPO was applied to scavenge mitochondrial ROS (mROS). Mice were subjected to severe MI and the occurrence of LVA-SCD was evaluated. Levels of mitochondrial ROS and calcium (mitoC[a.sup.2+]), cytosolic ROS (cytoROS), and calcium (cytoC[a.sup.2+]), RyR2 Ser-2814 phosphorylation, CaMKII Met-282 oxidation, mitochondrial membrane potential (MMP), and glutathione/oxidized glutathione (GSH/GSSG) ratio in the myocardia were detected. Dynamic changes in mROS after hypoxia were investigated using H9c2 cells. Moreover, the myocardial phosphoproteome was analyzed to explore the related mechanisms facilitating mROS-C[a.sup.2+] crosstalk and LVA-SCD. There was a high incidence (~33.9%) of LVA-SCD in early MI. Mice who underwent SCD displayed notably elevated levels of myocardial ROS and mROS, and the latter was validated in H9c2 cells. These mice also demonstrated overloads of cytoplasmic and mitochondrial C[a.sup.2+], decreased MMP and reduced GSH/GSSG ratio, upregulated RyR2-S2814 phosphorylation and CaMKII-M282 oxidation and transient hyperphosphorylation of mitochondrial proteomes in the myocardium. mROS-specific scavenging by a mitochondria-targeted antioxidant agent (MitoTEMPO) corrected these SCD-induced alterations. S2814A mice with a genetically inactivated CaMKII phosphorylation site in RyR2 exhibited decreased overloads in cytoplasmic and mitochondrial C[a.sup.2+] and demonstrated similar effects as MitoTEMPO to correct SCD-induced changes and prevent SCD post-MI. The data confirmed crosstalk between mROS and C[a.sup.2+] in promoting LVA-SCD. Therefore, we provided evidence that there is a higher incidence of LVA-SCD in early MI, which may be attributed to a positive feedback loop between mROS and C[a.sup.2+] imbalance.